Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice

Fig. 5

Subcutaneous metastasis. The metastasis shows the same characteristics of the rectal cancer. a H&E stain (100X OM). b Synaptophysin IHC (100X OM). c TTF1 IHC (100X OM). d Ki67 IHC (100X OM)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us